What is Biogen's investments - amortized cost basis?

Biogen (BIIB) reported investments - amortized cost basis of $1.37B in Q1 2026.

What is the long-term trend for Biogen's investments - amortized cost basis?

Over 3 years (2020 to 2025), Biogen's investments - amortized cost basis has grown at a -15.4% compound annual growth rate (CAGR), from $2.05B to $1.24B.

Discontinued — last reported Q1 '16

Non-Current Assets

Investments - Amortized Cost Basis

Biogen Investments - Amortized Cost Basis increased by 10.4% to $1.37B in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Investments - Amortized Cost Basis shows a downward trend with a -15.4% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

First reportedQ2 2015

Last reportedQ1 2016

Metric ID: investments_amortized_cost

Historical Data

12 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '25	Q4 '25	Q1 '26
Value	$2.22B	$2.38B	$2.44B	$3.02B	$3.28B	$2.12B	$2.20B	$3.13B	$4.69B	$97.60M	$1.24B	$1.37B
QoQ Change	—	+7.1%	+2.3%	+23.9%	+8.6%	-35.3%	+3.6%	+42.5%	+49.6%	-97.9%	>999%	+10.4%
YoY Change	—	—	—	—	+47.5%	-10.9%	-9.7%	+3.8%	+42.9%	—	—	—

Range$97.60M – $4.69B

CAGR-16.2%

Avg YoY Growth+14.7%

Median YoY Growth+3.8%

Current Streak2 quarters growth

Frequently Asked Questions

What is Biogen's investments - amortized cost basis?: Biogen (BIIB) reported investments - amortized cost basis of $1.37B in Q1 2026.
What is the long-term trend for Biogen's investments - amortized cost basis?: Over 3 years (2020 to 2025), Biogen's investments - amortized cost basis has grown at a -15.4% compound annual growth rate (CAGR), from $2.05B to $1.24B.